Isolation, characterization, and molecular identification of Candida species from urinary tract infections


1 Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

2 Department of Mycology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

3 Department of Bacteriology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

4 Department of Pathobiology, School of Veterinary Medicine, University of Tabriz, Tabriz, Iran

5 Statistical Researcher, Faculty of Electronic Unit, Islamic Azad University, Tehran, Iran


Background and Purpose: Candida species are reportedly the most common human fungal pathogens. The incidence of urinary tract infections (UTIs) caused by Candida pathogens has increased in recent decades. However, such infections rarely occur in the absence of any predisposing factors. Regarding this, the aim of the present study was to identify the Candida species causing UTIs and determine the predisposing factors for candiduria.

Materials and Methods: The current study was conducted on 1,450 urine samples obtained from patients suspected of UTI. Out of this number, 19 cases were candidiasis, and 2 cases were mixed infections caused by bacteria and fungi. Candida species were diagnosed differentially using the germ tube test, colony staining on CHROMagar medium, intracellular beta-glucosidase enzyme activity, and glucose absorption pattern. Then, the colonies with the same morphology were confirmed by the DNA sequencing of internal transcribed spacer regions.

Results: According to the results, 38%, 28.6%, 14.3%, and 9.5% of the isolates were identified as C. albicans, C. glabrata, C. tropicalis, and C. kefir/C. krusei, respectively. The presence of one or more predisposing factors was proved in all patients in whom diabetes was the most prevalent predisposing factor (21.1%).

Conclusion: Based on the obtained results, C. albicans species was the most prevalent fungal species. In addition, urinary fungal infections were less prevalent than bacterial urinary infections.


1. Behzadi P, Behzadi E, Ranjbar R. Urinary tract infections and Candida albicans. Cent European J Urol. 2015; 68(1): 96–101.
2. Bongomin F, Gago S, Oladele Rand DW. Denning Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. J. Fungi. 2017;3(4):57-62
3. Fisher JF, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infections: treatment. Clin Infect Dis 2011; 52:S457—66.
4. Rivett AG, perry JA, Cohen J. Urinary candidiasis, a Prospective study in hospitalized patient. Urol Ress. 1986; 14:153-161.
5. Odds FC, Davidson A. Room temperature use of CHROMagar canidida. Diagn Microbil and infect Dis. 2002; 58:147-150.
6. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30:14—8. Schonebeck J, Ainsehn S. The occurrence of yeast - like fungi in the urine inder normal conditions and in various type of urinary pathology. Scand J Urol Nephrol. 1982; 6:123-7.
7. Vaezi A, Fakhim H, Khodavaisy S, Alizadeh A, Nazeri M, Soleimani A, et al. Epidemiological and mycological characteristics of candidemia in Iran: A systematic review and meta-analysis. J Mycol Med. 2017; 27(2): 146-152.
8. Almirante B, Rodriguez D, Cuenca-Estrella M, Almela M, Sanchez F, , Ayats J, et al. The Barcelona Candidemia Project Study Group. Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections:Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006; 44 (5): 1681-5.
9. Rudramurthy SM, Chakrabarti A, Paul RA, Sood P, Kaur H, Capoor MR, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother 2017; 72(6): 1794-1801. 
10. Cortese YJ, Wagner VE, Tierney M, Devine D, Fogarty A. Review of Catheter-Associated Urinary Tract Infections and In Vitro Urinary Tract Models. J Healthcare Engi.2018; 1-16. 
11. Sobel JD, Fisher JF, Kauffman CA, Newman CA. Candida urinary tract infections—epidemiology. Clin Infect Dis. 2011; 52 (6): 433-6. 
12. Kalantar E, Marashi SM, Pormazaheri H, Mahmoudi E, Hatami S, Barari MA, et al. First experience of Candida non-albicans isolates with high antibiotic resistance pattern caused oropharyngeal candidiasis among cancer patients. J Can Res Ther. 2015; 11:388-90.
13. Salehi M, Ghasemian A, Shokouhi Mostafavi S K, Nojoomi F, Ashiani D, Rajabi H .The epidemiology of Candida species isolated from urinary tract infections. Arch Clin Infect Dis. 2016; 11(4):e37743.
14. Adrian HIS, Patel N, Spenceley N. Neonatal urinary ascites in renal Candidal infection. J Paedia Child Heal. 2006; 42 (6): 387-8.
15. Tan CW, Chlebicki MP. Urinary tract infections in adults. Singapore Med J.2016; 57(9): 485-490.
16. Farris AB, Ellis CL, Rogers TE, Chon WJ, Chang A, Meehan SM. Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients. Clin Kidney J. 2017; 10(2):240–248.
17. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, and et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62:e1-50.
18. Rezai MS, Vaezi A, Fakhim H, Soleimani A, Mohammad Jafari M, Mohseni S, Badali H. Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature, J Mycol Med 2017; 27: 261-265.
19. Emami S, Vaezi A, Hashemi SM, Faeli L, Diba K. In vitro activities of novel azole compounds ATTAF-1 and ATTAF-2 against fluconazole-susceptible and -resistant Isolates of Candida species. Antimicrob Agents Chemother 2016; 27(1):2793-802.
20. Marinho SA, Teixeira A , Santos OS, Cazanova RF, Sanchez FCA, Cherubini K , Oliveira SD. Identification of Candida spp. by phenotypic tests and PCR. Brazi J Microbio. 2010; 41: 286-294.
21. Mahmoudi E, Saeidi M, Marashi MA, Moafi A, Mahmoodi V, Zeinolabedini Zamani M. In vitro activity of kombucha tea ethyl acetate fraction against Malassezia species isolated from seborrhoeic dermatitis. Curr Med Mycol 2016; 2(4): 30-36. 22. Al-Badr A, Al-Shaikh G. Recurrent Urinary Tract Infections Management in Women, A review. Sultan Qaboos Univ Med J. 2013; 13(3): 359–367.
Volume 5, Issue 2
June 2019
Pages 33-36
  • Receive Date: 09 July 2019
  • Revise Date: 30 July 2019
  • Accept Date: 09 July 2019
  • First Publish Date: 09 July 2019